Safety and Efficacy Study of an A1-Adenosine Receptor Agonist to Slow Heart Rate in Atrial Fibrillation

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Atrial Fibrillation
Interventions
DRUG

DTI-0009

Trial Locations (1)

Unknown

Multiple locations, Richmond

Sponsors
All Listed Sponsors
lead

Aderis Pharmaceuticals

INDUSTRY